Plenary I will showcase the top-scoring late-breaking abstracts. Each late-breaking abstract presentation is followed by a live-stream Q&A with the moderator and the abstract's presenting author. This plenary session will conclude with the Presential Address and award aknowledgements.
Read more...Advances in the field of neuromodulation are increasingly dependent on integrating advanced technologies. During this session, we will explore two exceptional examples, including the advanced integration of robotics and neuromodulation for stroke rehabilitation and using advanced intracranial mapping and analytic techniques to understand how both depression and deep brain stimulation affect brain activity. This session will also highlight a major innovation in restoring movement in spinal cord injury.
Read more...Neuromodulation therapies are being developed and deployed at a fast pace. Research of high quality is required to establish a scientific basis to guide clinical practice and to ensure delivery of efficacious and safe neuromodulation therapies to patients and support from governments, funders, and regulatory agencies. The traditional RCT design has undergone several innovative modifications. The use of large databases that include patient-reported and relevant outcomes has opened the possibility of answering research questions in neuromodulation with confidence. This session will focus on innovations in RCT design, ways to involve funders and regulators in the research process, and explore processes for developing robust systems to sustain ongoing research in neuromodulation.
Read more...Throughout neuromodulation, neurosurgical, and chronic pain literature, it has been demonstrated that access to, and outcomes after, neuromodulation-based procedures are significantly different for women and minorities. Factors contributing to these phenomena may implicit bias, cultural differences, and lack of representation of women and minorities in neuromodulation related specialties, medical societies, and academic leadership. This session will summarize the disparities in neuromodulation access and outcomes for women and minority groups. It will examine the current state of women and underrepresented minorities in neuromodulation and neuromodulation related fields, including medical societies. Importantly, it will describe potential solutions to improve access and outcomes.
Read more...The target audience for this session is clinicians that currently utilize or are interested in incorporating SCS and or DBS technologies into their clinical practice. Engineering concepts relevant to emerging technologies and mechanisms of action related to SCS and DBS will be presented.
Read more...Neurostimulation of the human brain is a proven treatment for epilepsy and movement disorders, such as Parkinson's disease and essential tremor. Stimulation is typically done 'open-loop', with settings determined by a clinician and changed little between programming sessions. However, newer methods of tailoring ongoing stimulation to individual patient states have shown great promise for more effective and more efficient therapies. This session will review applications of open- and closed-loop stimulation, along with upcoming trends in both technologies.
Read more...The majority of pain specialists deliver multimodal pain treatment, which has been shown to be more effective than individual treatments only. Multimodal treatment can be done sequentially (one treatment at a time) or in parallel (combination therapy). However, there are no guidelines for how neuromodulation can be part of this chain (sequential or parallel approaches) and perhaps used earlier on in the treatment of chronic pain, based on the growing strength of the evidence. Candidates for neuromodulation often present with some of the most complex and challenging chronic painful conditions, and it is unrealistic to expect a neuromodulation implant to resolve the many facets of chronic pain, which include not only physical pain, but deconditioning, behavioral comorbidities, and mental health co-morbidities. This session will focus on multimodal pain care in the neuromodulation patient, including adjunctive interventional therapies, medical therapies, and rehabilitation medicine approaches to help optimize neuromodulation outcomes.
Read more...Repetitive Transcranial Magnetic Stimulation (rTMS) is indicated for the treatment of Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). The technique also can be beneficial for the off-label treatment of other conditions including chronic pain, tinnitus, and addictions, among other neuropsychiatric illnesses. This session will review the technique of rTMS treatment, possible mechanisms of action, and applications of TMS to conditions beyond MDD and OCD.
Read more...